In8bio Inc (INAB) — Financial Flexibility Index

Latest as of June 2026: -1.04x

In8bio Inc (INAB) has a Financial Flexibility Index of -1.04x as of June 2026. Free cash flow of $-3.51 Million (operating CF $-3.75 Million minus capex $233.00K) represents -1% of total liabilities ($3.38 Million). Check In8bio Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Financial Flexibility Index

-1.04x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-3.51 Million
Operating CF − Capex

Total Liabilities

$3.38 Million
USD

Capital Expenditures

$233.00K
USD

In8bio Inc Financial Flexibility Index (2018–2025)

Historical Financial Flexibility Index trend for In8bio Inc across 8 annual periods. For the full cash flow conversion analysis, see INAB cash generation efficiency.

Annual Financial Flexibility Index for In8bio Inc (2018–2025)

Year-by-year free cash flow to debt coverage for In8bio Inc. Explore In8bio Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -2.69x $-12.71 Million $-12.71 Million $4.72 Million ▲ +27.6%
2024 -3.72x $-24.05 Million $-24.15 Million $6.47 Million ▼ -43.4%
2023 -2.59x $-22.74 Million $-23.34 Million $8.77 Million ▼ -30.9%
2022 -1.98x $-20.42 Million $-24.12 Million $10.31 Million ▲ +39.4%
2021 -3.27x $-13.20 Million $-13.51 Million $4.04 Million ▼ -24.0%
2020 -2.64x $-6.82 Million $-7.13 Million $2.59 Million ▲ +13.0%
2019 -3.03x $-4.47 Million $-4.80 Million $1.48 Million ▼ -87.9%
2018 -1.61x $-2.01 Million $-2.77 Million $1.25 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities